NOVEL DIRECTION IN ADHERENCE ASSESSMENT — FOCUS ON THE GERIATRIC SYNDROMES
https://doi.org/10.15829/1728-8800-2017-3-46-51
Abstract
Aim. To investigate on the factors determining the adherence to optimal treatment in older age patients with chronic heart failure (CHF) in outpatient setting.
Material and methods. Into the open, comparative single-movement non-randomized study, 80 CHF patients were included at the age ≥60 y.o. Comparison group consisted of 40 patients (18 males, 22 females) with non-CHF cardiovascular disorders. Patients underwent the comorbidity assessment, laboratory and echocardiographic parameters, 6-minute walking test, cognitive status, treatment adherence, bi-photon x-ray absorptiometry. Criteria for frailty were 3 points by FRAIL (Fatigue, Resistance, Ambulation, Illnesses, Loss of Weight).
Results. The adherent to treatment were 40% of CHF patients, and 75% in comparison group (p<0,001). In monofactorial analysis there was correlation of treatment adherence with the level of cognition by Mini-mental State Examination — odds ratio (OR) 1,5; 95% confidence interval (CI) 1,2-1,9 (р<0,001), frailty — OR 3,5; 95% CI 1,3-9,5 (р=0,011), osteoporosis — OR 2,98; 95% CI 1,0-8,9 (р=0,050), comorbidity by Charlson — OR 1,21; 95% CI 1,0-1,5 (р=0,050).
Conclusion. Adherent to treatment were 40% of outpatients with CHF at the age ≥60 y.o. Multiple comorbidities, impaired cognition status, osteoporosis, frailty influenced negatively the adherence to treatment in older persons with CHF.
About the Authors
I. I. Chukaeva
N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Russian Federation
Moscow
V. N. Larina
N. I. Pirogov Russian National Research Medical University (RNRMU)
Moscow
Moscow
D. G. Karpenko
N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
V. G. Larin
N. I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Russian Federation
Moscow
References
1. Mareev VYu, Ageev FT, Arutyunov GP, et al. National recommendations of OCCH, PKO and PHMOT about diagnostics and treatment of HSN (fourth revision). Heart failure of 2013; 7 (81): p. 405. Russian (Мареев В. Ю., агеев Ф. т., арутюнов Г. П. и др. Национальные рекомендации ОССН, РКО и РНМОт по диагностике и лечению ХСН (четвертый пересмотр). Сердечная Недостаточность 2013; 7 (81); с. 405).
2. Störk S, Kavoliuniene A, Vinereanu D, et al. What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative. Eur J of Heart Fail 2016; 18: 66-70.
3. Мentz R, Kelly J, von Lueder T, et al. Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction. JACC 2014; 64(21): 2281-93.
4. Guyatt G, Thompson P, Berman L, et al. How should we measure function in patients with chronic heart and lung disease? J Chron Dis 1985; 38, Suppl 6: 517-24.
5. Charlson M, Pompei P, Ales K, Mackenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373-83.
6. Morley J, Malmstrom T, Miller D. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging 2012; 16 (7): 601-8.
7. Ponikowski P, Voors A, Anker S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016; doi:10.1093/eurheartj/ehw128.
8. Beard J, Officer A, de Carvalho I, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016; 387: 2145-54.
9. Efremova EV, Mevzorov MV, Sabitov IA. Commitment to treatment of patients with chronic heart failure in the conditions of a komorbidnost. Clinical of medicine 2015; 10: 20-4. Russian (ефремова е. В., Мевзоров М. В., Сабитов и. а. Приверженность к лечению больных с хронической сердечной недостаточностью в условиях коморбидности. Клиническая медицина 2015;10: 20-4).
10. Yancy C, Fonarow G, Albert N, et al. Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF). Am J Cardiol 2010; 105: 255-60.
11. McLennan S, Pearson S, Cameron J, Stewart S. Prognostic importance of cognitive impairment in chronic heart failure patients: Does specialist management make a difference? Eur J Heart Failure 2006; 8: 494-501.
12. Vogels R, Scheltens P, Schroeder-Tanka J, Weinstein H. Cognitive impairment in heart failure: A systematic review of the literature. Eur J Heart Fail 2007; 5 (9): 440-9.
13. Murad K, Goff D, Morgan T, et al. Burden of Comorbidities and Functional and Cognitive Impairments in Elderly Patients at the Initial Diagnosis of Heart Failure and Their Impact on Total Mortality: The Cardiovascular Health Study. JACC Heart Fail 2015; 3 (7): 542-50.
14. van Deursen V, Urso R, Laroche C, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J of Heart Fail 2014; 16: 103-11.
15. Luttik M, Jaarsma T, van Geel P, et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail 2014; 16: 1241-8.
Supplementary files
|
1. Направительное письмо с информацией | |
| Subject | ||
| Type | Исследовательские инструменты | |
Download
(85KB)
|
Indexing metadata ▾ | |
Review
For citations:
Chukaeva I.I., Larina V.N., Karpenko D.G., Larin V.G. NOVEL DIRECTION IN ADHERENCE ASSESSMENT — FOCUS ON THE GERIATRIC SYNDROMES. Cardiovascular Therapy and Prevention. 2017;16(3):46-51. (In Russ.) https://doi.org/10.15829/1728-8800-2017-3-46-51
Views:
752
Email this article 
